Palonosetron has been found to be effective in treating chemotherapy-induced nausea and vomiting, but no other studies that have compared it with the other 5-HT3 RAs are currently available.
Russell L. Knoth, PhD
Advertisement
Articles by Russell L. Knoth, PhD
Advertisement
Latest Updated Articles
- 5-HT3 Receptor Antagonist Effects in Cancer Patients With Multiple Risk Factors
Published: May 15th 2015 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
GLP-1 Receptor Agonists Show Promise Across Alcohol, Opioid, and Tobacco Use Disorders
2
TACTI-004 Trial Studying Eftilagimod Alfa With Pembrolizumab in Advanced NSCLC to Begin Evaluation
3
UConn’s Medical Writing Certificate Program: It’s Just "Write"
4
Pharmacy Policy Updates for October 2025
5
